Tag: covid-19 treatment

covid-19 treatment

Latest News

A Celltrion researcher holds a vial of CT-P59, the company's Covid-19 treatment. [NEWS1]

Celltrion's $521 million net is up 20.1%

Celltrion reported 623.7 billion won ($521 million) in net profit in 2021, up 20.1 percent on year, according to a regulatory filing on Wednesday.

2022.2.16

Inhalable Regkirona found safe in Phase 1 clinical trial

Celltrion said Monday Phase 1 clinical trials of an inhalable form of Regkirona produced meaningful results confirming safety.

2022.2.7

Most popular

Celltrion’s Regkirona, the first homegrown Covid-19 treatment [CELLTRION]

Regkirona gets temporary approval from Switzerland

Regkirona, Korea’s first Covid-19 treatment, won two-year temporary use authorization from regulators in Switzerland, developer Celltrion said Friday.

2022.1.14

Evusheld, AstraZeneca's antibody treatment for Covid-19. [AP/YONHAP]

Samsung Biologics expands partnership with AstraZeneca

Samsung Biologics will manufacture an AstraZeneca cancer treatment under a contract manufacturing organization (CMO) deal, strengthening its strategic partnership with the British pharmaceutical firm.

2021.12.14

Celltrion’s Regkirona, the first homegrown Covid-19 treatment [CELLTRION HEALTHCARE]

Regkirona deals signed with 18 countries by Celltrion Healthcare

Celltrion Healthcare has signed deals for Regkirona, Korea's first Covid-19 treatment, with 18 countries.

2021.12.9

Oh Sang-ki, CEO of Hyundai Bioscience, talks about the company’s oral Covid-19 treatment candidate, CP-COV03, during a press conference Tuesday at the Seoul Press Center, central Seoul. [HYUNDAI BIOSCIENCE]

Hyundai Bioscience's treatment should work with all variants

Hyundai Bioscience is developing a Covid-19 treatment that will remain effective for all kinds of variants, the company said.

2021.12.7

Celltrion’s Regkirona, the first homegrown Covid-19 treatment [CELLTRION]

Regkirona gets conditional use approval in Australia

Regkirona, Korea’s first Covid-19 treatment, won conditional use approval from regulators in Australia, manufacturer Celltrion said Tuesday.

2021.12.7

CrystalGenomics' Covid treatment performs well in trials

CrystalGenomics said Thursday that animal tests of its oral Covid-19 treatment candidate confirmed its effectiveness against the Delta variant.

2021.12.2

Celltrion's Regkirona Covid-19 treatment [YONHAP]

Celltrion Healthcare signs Regkirona deals with 9 European countries

Celltrion Healthcare has signed agreements with nine European countries for the distribution of Regkirona, Korea's first Covid-19 treatment.

2021.11.30

Celltrion’s Regkirona, the first homegrown Covid-19 treatment [CELLTRION]

Celltrion's Regkirona receives conditional approval from Peru

Regkirona, Korea’s first Covid-19 treatment, won conditional use approval from regulators in Peru, Celltrion said Monday.

2021.11.22